Does TREPROSTINIL Cause Cardiac septal defect? 24 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 24 reports of Cardiac septal defect have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
24
Reports of Cardiac septal defect with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
4
Deaths
17
Hospitalizations
How Dangerous Is Cardiac septal defect From TREPROSTINIL?
Of the 24 reports, 4 (16.7%) resulted in death, 17 (70.8%) required hospitalization, and 1 (4.2%) were considered life-threatening.
Is Cardiac septal defect Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 24 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Cardiac septal defect?
ALBUTEROL (104)
RAMIPRIL (103)
PANTOPRAZOLE (71)
ASPIRIN (70)
RIVAROXABAN (65)
EZETIMIBE (63)
HYDROXYCHLOROQUINE (63)
PREDNISOLONE (63)
TACROLIMUS (63)
TORSEMIDE (63)
Which TREPROSTINIL Alternatives Have Lower Cardiac septal defect Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE